Related Experiment Video
Updated: May 13, 2026

Production of Nurr-1 Specific Polyclonal Antibodies Free of Cross-reactivity Against Its Close Homologs, Nor1 and Nur77
Published on: August 17, 2015
Dichotomous roles for the orphan nuclear receptor NURR1 in breast cancer
Shawn Llopis1, Brittany Singleton, Tamika Duplessis
1Division of Basic Pharmaceutical Sciences, College of Pharmacy, Xavier University of Louisiana, New Orleans, LA 70125, USA.
Background:
NR4A orphan nuclear receptors are involved in multiple biological processes which are important in tumorigenesis such as cell proliferation, apoptosis, differentiation, and glucose utilization. The significance of NR4A family member NURR1 (NR4A2) in breast cancer etiology has not been elucidated. The purpose of this study was to ascertain the impact of NURR1 expression on breast transformation, tumor growth, and breast cancer patient survival.
Methods:
We determined the expression of NURR1 in normal breast versus breast carcinoma in tissue microarrays (immunohistochemistry), tissue lysates (immunoblot), and at the mRNA level (publically available breast microarrays). In addition NURR1 expression was compared among breast cancer patients in cohorts based on p53 expression, estrogen receptor α expression, tumor grade, and lymph node metastases. Kaplan-Meier survival plots were used to determine the correlation between NURR1 expression and relapse free survival (RFS). Using shRNA-mediated silencing, we determined the effect of NURR1 expression on tumor growth in mouse xenografts.
Results:
Results from breast cancer tissue arrays demonstrate a higher NURR1 expression in the normal breast epithelium compared to breast carcinoma cells (p ≤ 0.05). Among cases of breast cancer, NURR1 expression in the primary tumors was inversely correlated with lymph node metastases (p ≤ 0.05) and p53 expression (p ≤ 0.05). Clinical stage and histological grade were not associated with variation in NURR1 expression. In gene microarrays, 4 of 5 datasets showed stronger mean expression of NURR1 in normal breast as compared to transformed breast. Additionally, NURR1 expression was strongly correlated with increase relapse free survival (HR = 0.7) in a cohort of all breast cancer patients, but showed no significant difference in survival when compared among patients whom have not been treated systemically (HR = 0.91). Paradoxically, NURR1 silenced breast xenografts showed significantly decreased growth in comparison to control, underscoring a biphasic role for NURR1 in breast cancer progression.
Conclusions:
NURR1 function presents a dichotomy in breast cancer etiology, in which NURR1 expression is associated with normal breast epithelial differentiation and efficacy of systemic cancer therapy, but silencing of which attenuates tumor growth. This provides a strong rationale for the potential implementation of NURR1 as a pharmacologic target and biomarker for therapeutic efficacy in breast cancer.
Insights
NURR1 (NR4A2) is highly expressed in normal breast tissue but less so in breast cancer. While NURR1 silencing reduces tumor growth, its expression correlates with better survival and treatment efficacy, suggesting a complex role in breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- NR4A orphan nuclear receptors regulate key tumorigenesis processes like cell proliferation and apoptosis.
- The role of NURR1 (NR4A2) in breast cancer development remains unclear.
- Understanding NURR1's function is crucial for breast cancer research.
Purpose of the Study:
- To investigate the impact of NURR1 expression on breast cancer development.
- To analyze NURR1's correlation with tumor growth and patient survival.
- To determine NURR1's potential as a therapeutic target or biomarker.
Main Methods:
- NURR1 expression was assessed in normal and cancerous breast tissues using immunohistochemistry, immunoblotting, and mRNA analysis.
- Expression levels were compared across patient cohorts based on p53, estrogen receptor α, tumor grade, and lymph node status.
- Kaplan-Meier plots analyzed the relationship between NURR1 and relapse-free survival (RFS).
- Mouse xenograft models with NURR1 silencing were used to study tumor growth effects.
Main Results:
- NURR1 expression was higher in normal breast epithelium than in breast carcinoma.
- NURR1 levels inversely correlated with lymph node metastases and p53 expression in tumors.
- Higher NURR1 expression was linked to improved relapse-free survival in breast cancer patients.
- Silencing NURR1 in xenografts significantly reduced tumor growth, indicating a biphasic role.
Conclusions:
- NURR1 exhibits a dichotomous role in breast cancer, associated with normal differentiation and treatment efficacy.
- NURR1 expression correlates with better outcomes and response to systemic therapy.
- NURR1 presents a promising target for pharmacologic intervention and a biomarker for therapeutic efficacy in breast cancer.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Nucleolus
Co-activators and Co-repressors
Regulation of Nuclear Protein Sorting
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
